Amgen (AMGN) Goodwill (2009 - 2026)
Amgen (AMGN) recorded quarterly Goodwill of $18.7 billion in Q1 2026, little changed quarter-over-quarter from $18.7 billion in Q4 2025, and little changed on a YoY basis from $18.6 billion in Q1 2025.
Amgen (AMGN) Goodwill (2009 - 2026) Analysis & Trends
Amgen's Goodwill history runs 18 years deep, the most recent figure standing at $18.7 billion for Q1 2026.
- In Q1 2026, Goodwill changed 0.16% year-over-year to $18.7 billion; the TTM figure through Mar 2026 stood at $18.7 billion (changed 0.16% YoY), while the FY2025 annual figure was $18.7 billion, changed 0.23% from the prior year.
- Goodwill was $18.7 billion for Q1 2026 at Amgen, roughly flat from $18.7 billion in the prior quarter.
- In the past five years, Goodwill ranged from a high of $18.7 billion in Q4 2025 to a low of $14.8 billion in Q3 2022.
- Historically, Goodwill has averaged $17.2 billion across 5 years, with a median of $18.6 billion in 2024.
- Biggest YoY gain for Goodwill was 20.3% in 2024; the steepest drop was 0.04% in 2024.
- A 5-year view of Goodwill shows it stood at $15.5 billion in 2022, then increased by 19.96% to $18.6 billion in 2023, then rose by 0.04% to $18.6 billion in 2024, then advanced by 0.23% to $18.7 billion in 2025, then slipped by 0.03% to $18.7 billion in 2026.
- The last three Goodwill figures came in at $18.7 billion (Q1 2026), $18.7 billion (Q4 2025), and $18.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.67 Bn |
| Dec 31, 2025 | 18.68 Bn |
| Sep 30, 2025 | 18.68 Bn |
| Jun 30, 2025 | 18.67 Bn |
| Mar 31, 2025 | 18.65 Bn |
| Dec 31, 2024 | 18.64 Bn |
| Sep 30, 2024 | 18.66 Bn |
| Jun 30, 2024 | 18.62 Bn |
| Mar 31, 2024 | 18.57 Bn |
| Dec 31, 2023 | 18.63 Bn |
| Sep 30, 2023 | 15.51 Bn |
| Jun 30, 2023 | 15.53 Bn |
| Mar 31, 2023 | 15.53 Bn |
| Dec 31, 2022 | 15.53 Bn |
| Sep 30, 2022 | 14.85 Bn |
| Jun 30, 2022 | 14.87 Bn |
| Mar 31, 2022 | 14.90 Bn |
| Dec 31, 2021 | 14.89 Bn |
| Sep 30, 2021 | 14.67 Bn |
| Jun 30, 2021 | 14.68 Bn |